TransMedics Gr (NASDAQ:TMDX) is set to give its latest quarterly earnings report on Monday, 2023-05-01. Here’s what investors need to know before the announcement.
Analysts estimate that TransMedics Gr will report an earnings per share (EPS) of $-0.25.
TransMedics Gr bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Historical Earnings Performance
Last quarter the company beat EPS by $0.09, which was followed by a 20.55% increase in the share price the next day.
Here’s a look at TransMedics Gr’s past performance and the resulting price change:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.30 | -0.41 | -0.35 | -0.38 |
| EPS Actual | -0.21 | -0.25 | -0.41 | -0.38 |
| Price Change % | 20.55% | 24.0% | -10.34% | 40.33% |
Stock Performance
Shares of TransMedics Gr were trading at $78.6 as of April 27. Over the last 52-week period, shares are up 258.55%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for TransMedics Gr visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
